| __timestamp | Arrowhead Pharmaceuticals, Inc. | Catalent, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 334800000 |
| Thursday, January 1, 2015 | 34718089 | 337300000 |
| Friday, January 1, 2016 | 40998209 | 358100000 |
| Sunday, January 1, 2017 | 32022880 | 402600000 |
| Monday, January 1, 2018 | 19110051 | 462600000 |
| Tuesday, January 1, 2019 | 26556257 | 512000000 |
| Wednesday, January 1, 2020 | 52275890 | 577900000 |
| Friday, January 1, 2021 | 80981000 | 687000000 |
| Saturday, January 1, 2022 | 124431000 | 844000000 |
| Sunday, January 1, 2023 | 90932000 | 831000000 |
| Monday, January 1, 2024 | 98761000 | 935000000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Catalent, Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to SG&A cost management.
From 2014 to 2024, Catalent's SG&A expenses have consistently been higher, peaking at approximately 935% of Arrowhead's expenses in 2024. Despite this, Catalent's expenses have shown a steady growth trend, reflecting its expansive operational scale. In contrast, Arrowhead's SG&A costs have fluctuated, with a notable increase of over 400% from 2014 to 2022, indicating strategic investments in growth.
This data highlights the different strategies employed by these companies: Catalent's focus on scale and Arrowhead's targeted growth. Investors and industry analysts can glean insights into each company's operational priorities and financial health through these trends.
Comparing SG&A Expenses: Pfizer Inc. vs Catalent, Inc. Trends and Insights
Amgen Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Catalent, Inc.
Comparing SG&A Expenses: Neurocrine Biosciences, Inc. vs Catalent, Inc. Trends and Insights
Comparing SG&A Expenses: Catalent, Inc. vs ImmunityBio, Inc. Trends and Insights
Comparing SG&A Expenses: Catalent, Inc. vs Supernus Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Catalent, Inc. and BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Arrowhead Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.